Based on the provided news and technical data, here's the analysis for UNH's price prediction for next week:
Technical Analysis
Recent News Impact
Price Targets
Next Week's Forecast Based on technical indicators and news sentiment:
Trading Recommendation SELL with target price of $455 Rationale:
The stock is likely to remain under pressure in the short term due to ongoing investigations and sector-wide concerns about rising medical costs. However, long-term investors might find attractive entry points if the stock reaches the $455 support level.
The price of UNH is predicted to go up 3.87%, based on the high correlation periods with GT. The similarity of these two price pattern on the periods is 92.1%.
UNH
GT
Year
UNH Price Forecast($)
Potential Return(%)
2025
513.520
0.100
2026
650.000
19.820
2027
700.000
29.030
2028
720.000
32.720
2029
650.000
19.820
2030
850.000
56.680
UnitedHealth's strategy of providing medical insurance, pharmacy benefits, and healthcare services creates a powerful alignment of incentives that should help clients control their healthcare costs better than pure-play competitors.
As the leading provider of Medicare Advantage plans in the U.S., UnitedHealth should benefit from ongoing demographic shifts and the increasing popularity of these plans among seniors.
UnitedHealth has managed its balance sheet more conservatively than peers, giving it more flexibility in times of change.
Barclays
2025-01-17
Price Target
$655 → $642
Upside
+25.94%
Truist Securities
2025-01-06
Price Target
$625 → $610
Upside
+18.75%
Piper Sandler
2025-01-02
Price Target
$605 → $600
Upside
+18.93%